Intuit, Alphabet, Honeywell, BDX, Stryker Trending With Analysts - TipRanks.com
TipRanks highlights analyst rating changes for Intuit (INTU), Alphabet (GOOGL), Honeywell (HON), Becton Dickinson (BDX) and Stryker (SYK). Intuit was cut to Hold with a $304 target. Alphabet was upgraded to Buy, $425 target, after 2Q26 revenue +24% and cloud revenue +82%. Honeywell upgraded to Neutral, $265 target. BDX initiated Buy, $190 target. Stryker upgraded to Buy, $400 target.
How this was made
The 30-second read
Why it matters
The actionable element is the set of rating changes and revised price targets, each tied to a specific thesis (guidance risk for INTU, cloud and AI ad improvements for GOOGL, order trends for HON, 2027 headwind easing for BDX, and MedSurg pipeline plus higher organic growth for SYK).
Market read
This is a multi-name analyst call sheet. Traders may use it for near-term sentiment and positioning, but it is not a fundamental disclosure like earnings or regulatory action.
What to watch
For INTU, AI execution and DIY tax competition risks could worsen into FY27. For GOOGL, temporary free-cash-flow pressure from AI spending could delay the market’s acceptance of durable growth. For BDX and SYK, the bullish case depends heavily on forecast normalization and pipeline execution rather than newly reported results.
Background
TipRanks summarizes five analyst rating changes and the stated rationale for each stock.
Ticker impact
Intuit’s rating was cut from Buy to Hold, with a $304 target, and the analyst flags FY27 guidance and AI execution risk as downside catalysts.
Bias toward underperformance versus peers until the next earnings/investor-day catalysts.
The article provides a concrete downgrade and target change plus specific thesis items (FY27 guidance disappointment, AI execution, DIY tax competition).
Alphabet’s Class A shares were upgraded to Buy with a $425 target after 2Q26 results, including 24% revenue/profit growth and 82% cloud revenue growth.
Supports a positive bias and potential multiple expansion if investors accept the FCF normalization narrative.
The text includes an explicit upgrade, revised target, and multiple quantified operating drivers (cloud growth, margins, backlog).
Honeywell was upgraded to Neutral (Hold) with a $265 price objective after a broad-based quarter beat and raised 2026 guidance for organic growth, margins, and EPS.
Likely stabilizes the stock versus prior expectations, with upside dependent on order-driven second-half acceleration.
The article provides a specific upgrade, target, and quantified order/book-to-bill support, but the rating remains Neutral.
Becton Dickinson coverage was initiated with a Buy rating and a $190 target, arguing the market is overly pessimistic about vaccine softness and China procurement.
Potential upward drift if investors buy into the 2027 normalization and capital allocation thesis.
This is an initiation note with a valuation/rerating argument; the article does not provide new company-specific datapoints beyond the stated thesis.
Stryker was upgraded to Buy with a $400 target, with the analyst arguing investors misunderstand growth drivers and citing a MedSurg pipeline plus 9% to 10% organic growth potential.
Improves near-to-medium term upside skew if sector sentiment turns and growth expectations are repriced.
The article is primarily an analyst upgrade with forecast-based claims; it lacks fresh operational disclosures beyond the stated pipeline/growth estimates.
Market effects
Cross-sector read-through: upgrades/downgrades across software (INTU), mega-cap tech (GOOGL), industrials (HON), and healthcare tools (BDX, SYK) may influence relative positioning within their respective groups.
No explicit regional macro linkage; primarily US-listed large/mid-cap sentiment.
Limited. Mentions of China procurement (BDX) and global cloud/ads (GOOGL) are thesis elements, not new global events.
Counterpoint
Analyst targets and rating changes may not translate into sustained price moves if the underlying catalysts (earnings, investor day, 2027 normalization) are still far out.
Key entities
- companyIntuit
Rating cut to Hold with a $304 target; thesis highlights FY27 guidance risk and AI execution concerns.
- companyAlphabet
Upgraded to Buy with a $425 target after 2Q26 strength, including cloud growth and backlog visibility.
- companyHoneywell International
Upgraded to Neutral (Hold) with a $265 target after a broad-based quarter beat and raised 2026 guidance.
- companyBecton Dickinson
Coverage initiated with Buy and a $190 target, arguing headwinds are temporary and rerating is possible.
- companyStryker
Upgraded to Buy with a $400 target, arguing investors underestimate core growth and MedSurg pipeline strength.
